Authors: Peterson, Kyle; Kim, Samuel; Rehrig, Matthew; Stamp, Mike
Company Name: Abbott; AstraZeneca; BD; Eli Lilly and Company; GE; GlaxoSmithKline; Medtronic; Novartis; Novo Nordisk; Stryker
Number of pages: 62
Increasingly, companies are seeing opportunities to meet the needs of underserved populations in low- and middle-income countries, where they once saw little commercial interest. This report highlights how pharmaceutical and medical device companies are creating shared value in global health by enhancing their competitiveness while simultaneously addressing the global burden of disease — often working in partnership with governments, funders, and nonprofit organizations.